1. Home
  2. CCLD vs ARMP Comparison

CCLD vs ARMP Comparison

Compare CCLD & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$3.04

Market Cap

146.0M

Sector

Technology

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.31

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
ARMP
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.0M
125.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CCLD
ARMP
Price
$3.04
$5.31
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$1.50
$9.00
AVG Volume (30 Days)
494.3K
105.7K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$114,315,000.00
$5,054,000.00
Revenue This Year
$6.94
$8.43
Revenue Next Year
$18.66
N/A
P/E Ratio
$39.39
N/A
Revenue Growth
2.97
N/A
52 Week Low
$1.14
$0.90
52 Week High
$4.84
$16.34

Technical Indicators

Market Signals
Indicator
CCLD
ARMP
Relative Strength Index (RSI) 47.42 41.88
Support Level $2.99 $6.81
Resistance Level $3.19 $7.40
Average True Range (ATR) 0.14 0.70
MACD 0.01 -0.20
Stochastic Oscillator 38.89 4.48

Price Performance

Historical Comparison
CCLD
ARMP

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: